Uniphar PLC (GB:UPR) has released an update.
Uniphar PLC, a diversified international healthcare services company, reports a solid performance in the first half of 2024, with a 7% organic gross profit growth and strong liquidity, while confidently expecting to meet the current year’s EPS projections. The company highlights the significance of M&A in its growth strategy and maintains an active acquisition pipeline to boost future growth. CEO Ger Rabbette affirms the Group’s positive trajectory, aiming for a €200 million EBITDA medium-term target.
For further insights into GB:UPR stock, check out TipRanks’ Stock Analysis page.
